Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology

被引：38

作者：

Rhee, Chin Kook ^{[1
]}

Chau, Ngo Quy ^{[2
]}

Yunus, Faisal ^{[3
]}

Matsunaga, Kazuto ^{[4
]}

Perng, Diahn-Warng ^{[5
]}

机构：

[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Pulm Allergy & Crit Care Me, Seoul, South Korea

[2] Bach Mai Hosp, Ctr Resp Med, Hanoi, Vietnam

[3] Univ Indonesia, Persahabatan Natl Resp Ctr Hosp, Fac Med, Dept Pulmonol & Resp Med, Jakarta, Indonesia

[4] Yamaguchi Univ, Grad Sch Med, Dept Resp Med & Infect Dis, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan

[5] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan

来源：

RESPIROLOGY | 2019年 / 24卷 / 10期

关键词：

air pollution; bronchiectasis; chronic obstructive pulmonary disease; tuberculosis; OBSTRUCTIVE PULMONARY-DISEASE; INHALED FLUTICASONE FUROATE; AIR-FLOW OBSTRUCTION; PNEUMONIA RISK; SMOKE EXPOSURE; CORTICOSTEROIDS; HEALTH; PREVALENCE; TUBERCULOSIS; VILANTEROL;

D O I：

10.1111/resp.13633

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Chronic obstructive pulmonary disease (COPD) is a major disease in Asia. However, how to manage specifically Asian COPD patients has not been proposed. Awareness of COPD is very low and underdiagnosis/undertreatment is common in Asian countries. Low utilization of pulmonary function test and inhalers is also a problem. Moreover, high smoking prevalence and air pollution are barriers to managing Asian patients with COPD. The relatively low body mass index of Asian patients with COPD can increase their risk for experiencing adverse effects from COPD drugs. Physicians should consider the unique features of Asian populations with COPD such as the high prevalence rates of bronchiectasis and tuberculosis-destroyed lungs, biomass smoke exposure and parasitic infection.

引用

收藏

页码：1018 / 1025

页数：8

相关论文

共 56 条

[1] Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis [J].

Andrejak, Claire ;

Nielsen, Rikke ;

Thomsen, Vibeke O. ;

Duhaut, Pierre ;

Sorensen, Henrik Toft ;

Thomsen, Reimar Wernich .

THORAX, 2013, 68 (03) :256-262

[2] The effect of portable HEPA filter air cleaners on indoor PM2.5 concentrations and second hand tobacco smoke exposure among pregnant women in Ulaanbaatar, Mongolia: The UGAAR randomized controlled trial [J].

Barn, Prabjit ;

Gombojav, Enkhjargal ;

Ochir, Chimedsuren ;

Laagan, Bayarkhuu ;

Beejin, Bolor ;

Naidan, Gerel ;

Boldbaatar, Buyantushig ;

Galsuren, Jargalsaikhan ;

Byambaa, Tsogtbaatar ;

Janes, Craig ;

Janssen, Patricia A. ;

Lanphear, Bruce P. ;

Takaro, Tim K. ;

Venners, Scott A. ;

Webster, Glenys M. ;

Yuchi, Weiran ;

Palmer, Christopher D. ;

Parsons, Patrick J. ;

Roh, Young Man ;

Allen, Ryan W. .

SCIENCE OF THE TOTAL ENVIRONMENT, 2018, 615 :1379-1389

[3] Trends in cigarette smoking South Korea [J].

Choi, Sunhye ;

Kim, Yoonjung ;

Park, Suyeon ;

Lee, Jihye ;

Oh, Kyungwon .

EPIDEMIOLOGY AND HEALTH, 2014, 36

[4] Effectiveness of a portable air cleaner in removing aerosol particles in homes close to highways [J].

Cox, Jennie ;

Isiugo, Kelechi ;

Ryan, Patrick ;

Grinshpun, Sergey A. ;

Yermakov, Michael ;

Desmond, Colleen ;

Jandarov, Roman ;

Vesper, Stephen ;

Ross, James ;

Chillrud, Steven ;

Dannemiller, Karen ;

Reponen, Tiina .

INDOOR AIR, 2018, 28 (06) :818-827

[5] Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results [J].

Crim, C. ;

Calverley, P. M. A. ;

Anderson, J. A. ;

Celli, B. ;

Ferguson, G. T. ;

Jenkins, C. ;

Jones, P. W. ;

Willits, L. R. ;

Yates, J. C. ;

Vestbo, J. .

EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) :641-647

[6] Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial [J].

Crim, Courtney ;

Calverley, Peter M. A. ;

Anderson, Julie A. ;

Holmes, Andrew P. ;

Kilbride, Sally ;

Martinez, Fernando J. ;

Brook, Robert D. ;

Newby, David E. ;

Yates, Julie C. ;

Celli, Bartolome R. ;

Vestbo, Jorgen .

RESPIRATORY MEDICINE, 2017, 131 :27-34

[7] Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD [J].

Crim, Courtney ;

Dransfield, Mark T. ;

Bourbeau, Jean ;

Jones, Paul W. ;

Hanania, Nicola A. ;

Mahler, Donald A. ;

Vestbo, Jorgen ;

Wachtel, Andrew ;

Martinez, Fernando J. ;

Barnhart, Frank ;

Lettis, Sally ;

Calverley, Peter M. A. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (01) :27-34

[8] Bronchodilators use in patients with COPD [J].

Dong, Yaa-Hui ;

Hsu, Chia-Lin ;

Li, Ying-Ying ;

Chang, Chia-Hsuin ;

Lai, Mei-Shu .

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :1769-1779

[9] Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza A Systematic Review and Meta-analysis of Randomized Controlled Trials [J].

Dong, Yaa-Hui ;

Chang, Chia-Hsuin ;

Wu, Fe-Lin Lin ;

Shen, Li-Jiuan ;

Calverley, Peter M. A. ;

Lofdahl, Claes-Goran ;

Lai, Mei-Shu ;

Mahler, Donald A. .

CHEST, 2014, 145 (06) :1286-1297

[10] An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease [J].

Eisner, Mark D. ;

Anthonisen, Nicholas ;

Coultas, David ;

Kuenzli, Nino ;

Perez-Padilla, Rogelio ;

Postma, Dirkje ;

Romieu, Isabelle ;

Silverman, Edwin K. ;

Balmes, John R. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (05) :693-718

← 1 2 3 4 5 6 →